The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis-Reference-Cited by-同舟云学术

The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis

Published:2016-07-16 Issue:1 Volume:17 Page:
ISSN:1471-2474
Container-title:BMC Musculoskeletal Disorders
language:en
Short-container-title:BMC Musculoskelet Disord

Author:

Tada Yoshifumi^ORCID,Ono Nobuyuki,Suematsu Rie,Tashiro Satoko,Sadanaga Yuri,Tokuda Yukiko,Ono Yukihide,Nakao Yoshinobu,Maruyama Akihito,Ohta Akihide,Koarada Syuichi

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1186/s12891-016-1137-1

Reference35 articles.

1. McInnes IB, Schett G. The pathogensis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19.

2. Moreland L, Bate G, Kirkpatrick P. Abatecept. Nat Rev Drug Discov. 2006;5:185–6.

3. Kimura A, Kishimoto T. IL-6: Regulator of Treg/Th17 balance. Eur J Immunol. 2010;40:1830–5.

4. Nistala K, Wedderburn LR. Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology. 2009;48:602–6.

5. Miossec P. Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum. 2007;56:2111–5.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of regulatory T cells in pathogenesis and therapeutics of spondyloarthritis;Regulatory T Cells and Autoimmune Diseases;2024

2. Role of regulatory T cells in pathogenesis and therapeutics of Graves’ disease and Graves’ orbitopathy;Regulatory T Cells and Autoimmune Diseases;2024

3. NET-targeted therapy: effects, limitations, and potential strategies to enhance treatment efficacy;Trends in Pharmacological Sciences;2023-09

4. Impact of interleukin-6 on T cells in kidney transplant recipients;American Journal of Transplantation;2022-12

5. Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases;Autoimmunity Reviews;2022-06